海角破解版

EasySep? Mouse Streptavidin RapidSpheres? Isolation Kit

Immunomagnetic depletion of single or multiple unwanted mouse cell types labeled with biotinylated antibodies

New format, same high quality! You may notice that your kit contents and packaging look slightly different from previous orders. We are currently updating the format of select EasySep? Mouse kits to include a Mouse FcR blocker instead of Normal Rat Serum. With this change, all components will now be shipped in a single package, while providing the same cell isolation performance as before.

EasySep? Mouse Streptavidin RapidSpheres? Isolation Kit

Immunomagnetic depletion of single or multiple unwanted mouse cell types labeled with biotinylated antibodies

Catalog #
(Select a product)
Immunomagnetic depletion of single or multiple unwanted mouse cell types labeled with biotinylated antibodies
Request Pricing Request Pricing

Product Advantages


  • Fast and easy-to-use

  • No columns required

  • Untouched, viable cells

What's Included

  • EasySep? Mouse Streptavidin RapidSpheres? Isolation Kit (Catalog #19860)
    • EasySep? Streptavidin RapidSpheres? 50001, 1 mL
    • EasySep? Mouse FcR Blocker (Catalog #18731), 0.5 mL
  • RoboSep? Mouse Streptavidin RapidSpheres? Isolation Kit (Catalog #19860RF)
    • EasySep? Streptavidin RapidSpheres? 50001, 1 mL
    • EasySep? Mouse FcR Blocker (Catalog #18731), 0.5 mL
    • RoboSep? Empty Vial
    • RoboSep? Buffer (Catalog #20104)
    • RoboSep? Filter Tips (Catalog #20125)
Products for Your Protocol
To see all required products for your protocol, please consult the Protocols and Documentation.

Overview

Efficiently deplete single or multiple unwanted cell types labeled with biotinylated antibodies from mouse splenocytes or other tissue samples by immunomagnetic positive selection, with the EasySep? Mouse Streptavidin RapidSpheres? Isolation Kit. Widely used in published research for more than 20 years, EasySep? combines the specificity of monoclonal antibodies with the simplicity of a column-free magnetic system.

This straightforward, optimized EasySep? procedure involves labeling unwanted cells with biotinylated antibodies and streptavidin-coated magnetic particles called Streptavidin RapidSpheres?. Labeled cells are separated from untouched cells using an EasySep? magnet and by simply pouring off the unlabeled cells. The desired cells remain in the tube. Following magnetic cell isolation, desired cells are ready for downstream applications, such as flow cytometry, culture, or DNA/RNA extraction.

This kit is not recommended for positive selection of mouse cells of interest. For positive selection, use EasySep? Mouse Biotin Positive Selection Kit II (Catalog #17665).

Learn more about how immunomagnetic EasySep? technology works or how to fully automate immunomagnetic cell isolation with RoboSep?. Explore additional products optimized for your workflow, including culture media, supplements, antibodies, and more.
Magnet Compatibility
? EasySep? Magnet (Catalog #18000)
? “The Big Easy” EasySep? Magnet (Catalog #18001)
? RoboSep?-S (Catalog #21000)
Subtype
Cell Isolation Kits
Cell Type
B Cells, Dendritic Cells, Granulocytes and Subsets, Hematopoietic Stem and Progenitor Cells, Macrophages, Marrow Stromal Cells, Mesenchymal Stem and Progenitor Cells, Monocytes, Mononuclear Cells, Myeloid Cells, NK Cells, Other, Plasma, T Cells
Species
Mouse
Sample Source
Other, Spleen
Selection Method
Depletion, Negative
Application
Cell Isolation
Brand
EasySep, RoboSep
Area of Interest
Immunology

Data Figures

Typical Mouse Streptavidin Rapidspheres™ CD4 (CD3+CD8-) Depletion Profile

Figure 1. Typical Mouse Streptavidin Rapidspheres™ CD4 (CD3+CD8-) Depletion Profile

Typical Mouse Streptavidin Rapidspheres™ CD8 (CD3+CD4-) Depletion Profile

Figure 2. Typical Mouse Streptavidin Rapidspheres™ CD8 (CD3+CD4-) Depletion Profile

Typical Mouse Streptavidin Rapidspheres™ CD19 (CD19+CD45+) Depletion Profile

Figure 3. Typical Mouse Streptavidin Rapidspheres™ CD19 (CD19+CD45+) Depletion Profile

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
19860RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
19860
Lot #
All
Language
English
Document Type
Product Name
Catalog #
19860RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
19860RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
19860RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
19860RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
19860
Lot #
All
Language
English
Document Type
Product Name
Catalog #
19860
Lot #
All
Language
English
Document Type
Product Name
Catalog #
19860
Lot #
All
Language
English

Resources and Publications

Publications (12)

GPR43 in eosinophils suppresses the emergence of pathogenic Siglec-Fhi neutrophils in allergic airway inflammation in mice J. Yu et al. Nature Communications 2025 Nov

Abstract

Eosinophils are major effector cells in type 2 immune responses, contributing to host defense and allergic diseases. They also contribute to maintaining tissue homeostasis by regulating various immune cell types, including neutrophils. Here we show that eosinophils directly associate with neutrophils in the lungs of asthma-induced mice. Eosinophil-specific deficiency of the short-chain fatty acid receptor, GPR43, results in hyperactivation of eosinophils and increases the expression of neutrophil chemoattractants and PECAM-1, thereby enhancing the interaction between eosinophils and neutrophils. This interaction exposes neutrophils to eosinophil-derived IL-4 and GM-CSF, which induce the conversion of conventional neutrophils into more pathogenic, Siglec-Fhi neutrophils capable of enhancing Th17 cell differentiation and aggravating asthma symptoms in mouse models. Our results thus implicate GPR43 as a critical regulator of eosinophils, and describe eosinophil-mediated modulation of neutrophil differentiation and function. Eosinophils contribute to type 2 immunity, but their interaction with neutrophils in this context is incompletely understood. Here the authors use mouse asthma models and in vitro culture to show that eosinophil-specific deficiency of GPR43 promotes Siglec-Fhi neutrophil differentiation and downstream induction of Th17 to aggravate lung inflammation and asthma.
Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infection Nature Communications 2025 Feb

Abstract

Type I Interferons (IFN-I) are central to host protection against viral infections, with plasmacytoid dendritic cells (pDC) being the most significant source, yet pDCs lose their IFN-I production capacity following an initial burst of IFN-I, resulting in susceptibility to secondary infections. The underlying mechanisms of these dynamics are not well understood. Here we find that viral infection reduces the capacity of pDCs to engage both oxidative and glycolytic metabolism. Mechanistically, we identify lactate dehydrogenase B (LDHB) as a positive regulator of pDC IFN-I production in mice and humans; meanwhile, LDHB deficiency is associated with suppressed IFN-I production, pDC metabolic capacity, and viral control following infection. In addition, preservation of LDHB expression is sufficient to partially retain the function of otherwise exhausted pDCs, both in vitro and in vivo. Furthermore, restoring LDHB in vivo in pDCs from infected mice increases IFNAR-dependent, infection-associated pathology. Our work thus identifies a mechanism for balancing immunity and pathology during viral infections, while also providing insight into the highly preserved infection-driven pDC inhibition. Plasmacytoid dendritic cells (pDC) are the major IFN-I-producing cells, but this production returns to baseline soon after viral infection. Here the authors show that this decrease in IFN-I production and related pDC functions may be attributed to suppressed oxidative and glycolytic metabolism of pDCs, with lactate dehydrogenase B identified as a regulator.
Thymocyte Maturation and Emigration in Adult Mice. K. Joannou et al. Journal of immunology (Baltimore, Md. : 1950) 2022 may

Abstract

Several unique waves of ?? T cells are generated solely in the fetal/neonatal thymus, whereas additional ?? T cell subsets are generated in adults. One intriguing feature of ?? T cell development is the coordination of differentiation and acquisition of effector function within the fetal thymus; however, it is less clear whether this paradigm holds true in adult animals. In this study, we investigated the relationship between maturation and thymic export of adult-derived ?? thymocytes in mice. In the Rag2pGFP model, immature (CD24+) ?? thymocytes expressed high levels of GFP whereas only a minority of mature (CD24-) ?? thymocytes were GFP+ Similarly, most peripheral GFP+ ?? T cells were immature. Analysis of ?? recent thymic emigrants (RTEs) indicated that most ?? T cell RTEs were CD24+ and GFP+, and adoptive transfer experiments demonstrated that immature ?? thymocytes can mature outside the thymus. Mature ?? T cells largely did not recirculate to the thymus from the periphery; rather, a population of mature ?? thymocytes that produced IFN-? or IL-17 remained resident in the thymus for at least 60 d. These data support the existence of two populations of ?? T cell RTEs in adult mice: a majority subset that is immature and matures in the periphery after thymic emigration, and a minority subset that completes maturation within the thymus prior to emigration. Additionally, we identified a heterogeneous population of resident ?? thymocytes of unknown functional importance. Collectively, these data shed light on the generation of the ?? T cell compartment in adult mice.
New format, same high quality! You may notice that your kit contents and packaging look slightly different from previous orders. We are currently updating the format of select EasySep? Mouse kits to include a Mouse FcR blocker instead of Normal Rat Serum. With this change, all components will now be shipped in a single package, while providing the same cell isolation performance as before.